Microbot Medical Inc. 8-K

What Happened

• Microbot Medical Inc. (MBOT) filed an 8‑K on July 7, 2026, announcing that the company reported greater than 100% growth in revenue and in new customers for the quarter ended June 30, 2026, compared to the quarter ended March 31, 2026. The filing also includes a Regulation FD disclosure and a press release attached as an exhibit.

Key Details

• Reported metric: >100% growth in revenue quarter‑over‑quarter (Q2 2026 vs Q1 2026).
• Customer metric: >100% growth in new customers quarter‑over‑quarter (Q2 2026 vs Q1 2026).
• Filing date: 8‑K filed July 7, 2026; quarter end date: June 30, 2026.
• The filing includes a press release (Exhibit 99.1) and standard forward‑looking statements disclosure.

Why It Matters

• A reported >100% quarter‑over‑quarter increase in both revenue and new customers signals short‑term operational momentum that may affect investor sentiment and trading interest.
• The 8‑K provides headline metrics but does not replace a full earnings release or audited financial statements; investors should look for further detailed financial results or management commentary for context and dollar amounts.
• The Regulation FD disclosure and attached press release indicate the company made this information public to avoid selective disclosure.